Human Genome Sciences Benlysta Drug Approval (HGSI) - 0 views
-
Brian Plain on 12 Nov 10Tomorrow is the big day! We finally see how Human Genome Sciences Blockbuster Hopes on Lupus Drug Benlysta Pans Out based on Human Genome Sciences Benlysta® Drug Approval for Lupus Patients (HGSI) by the FDA Panel Notes. At our Trading School, we've been covering this stock for some times and we're very pleased with the drug benefits that Benlysta® brings to patients worldwide. We've seen positive results in near-term and long-term periods and we expect the FDA to clear Benlysta on December 9, 2010 and we expect positive FDA Panel notes tomorrow November 12, 2010.